An article published in the Journal of Translational Medicine in May 2008, brought to light research that is being conducted by several Italian scientists, which exposes the possibility of treatment for mesothelioma cancer with nonsteroidal anti-inflammatory drugs (NSAIDs). These drugs, NSAIDs, are anti-inflammatory and analgesic drugs often found in small doses in common pain relieving over-the-counter drugs such as aspirin. Scientists used a combination of two of the NSAIDs, Piroxicam and cisplatin (CDDP), and found the results produced anti-tumoral activity within malignant mesothelioma cancer cells.
The research, considered by some to be breakthrough research for victims of mesothelioma cancer, will continue to be studied but the initial results highlighted a significant and positive trend toward cancer cell repression and prevention, particularly for malignant mesothelioma. According to researchers, because of the potential treatments' anti-tumoral results, advances in therapy treatment may be further explored.
What is Malignant Mesothelioma Cancer?
There are several varieties of mesothelioma cancer, however, malignant mesothelioma is considered one of the most lethal. It has been determined that malignant mesothelioma victims often have a median survival of only a few months in both untreated and treated cases, according to the study." Malignant mesothelioma is a rare cancer with malignant cancer cells forming on the sac lining of the chest or abdomen, according to the National Cancer Institute (NCI). It is often associated with exposure to airborne asbestos particles and fibers, which increases the risk of malignant mesothelioma developing in an individual.
Signs and Symptoms of Malignant Mesothelioma
Malignant mesothelioma is often marked by several symptoms including lumps in abdomen, weight loss, pain or swelling in the abdomen, pain under the rib cage and difficulties breathing. The cancer can also often cause fluid retention in the abdomen or around the lungs. The cancer often has symptoms similar to other conditions making misdiagnosis of the condition common.
Medical professionals have even admitted that malignant mesothelioma and lung cancer are very similar and differentiating between the two is difficult, however, there is an array of tests that physicians can use to increase the potential for a more accurate diagnosis. Tests for diagnosis may include the patient enduring physical exams, chest x-rays, biopsy of body tissues, getting a complete blood count (CBC), cytologic exam, which is an exam of cells under a microscope, or a bronchoscopy procedure where a bronchoscope is inserted into the nose or mouth for a better view of airways.
Diagnosing and Treating Malignant Mesothelioma
While treatments for mesothelioma are rare in and of themselves, it becomes increasingly difficult to treat malignant mesothelioma because of the severity of the condition. Factoring in the best method of treatment often depends on several factors. The following is a detailed list of these factors, according to the NCI:
Page 1 of 2 :: First | Last :: Prev | 1 2 | Next
|